KATA PENGANTAR

Dalam penyusunan, banyak pihak yang telah membantu dari awal hingga
tugas ini selesai, baik moral maupun material. Oleh karena itu pada kesempatan
ini, penulis mengucapkan terima kasih kepada :
1. dr. Made Mahayasa, Sp.B KBD selaku pembimbing sari pustaka ini
atas bimbingan, saran, dan masukan selama penyusunan.
2. Dokter-dokter residen yang bertugas di Bagian/SMF Ilmu Bedah
RSUP Sanglah/Fakultas Kedokteran Universitas Udayana, atas
bimbingan dan saran-sarannya.
3. Rekan-rekan dokter muda yang bertugas di Bagian/SMF Ilmu Bedah
RSUP Sanglah/Fakultas Kedokteran Universitas Udayana, atas
bantuannya dalam penyusunan sari pustaka ini.
Penulis menyadari bahwa sari pustaka ini masih jauh dari sempurna, untuk
itu diharapkan saran dan kritik yang membangun. Semoga tugas ini dapat
memberi manfaat bagi pihak yang berkepentingan.

Denpasar, 5 Agustus 2012

Penulis

ii

DAFTAR ISI
HALAMAN
JUDUL
..........................................................................................................................
..........................................................................................................................
i
KATA
PENGANTAR
..........................................................................................................................
..........................................................................................................................
ii
DAFTAR
ISI
..........................................................................................................................
..........................................................................................................................
iii
BAB
I
PENDAHULUAN
..........................................................................................................................
..........................................................................................................................
1
BAB
II
KAJIAN
PUSTAKA
..........................................................................................................................
..........................................................................................................................
3
2.1
Konsep
EGDT
.................................................................................................................
.................................................................................................................
3
2.2
Kontroversi
Terhadap
EGDT
.................................................................................................................
.................................................................................................................
13
BAB
III
KESIMPULAN
..........................................................................................................................
..........................................................................................................................
17
DAFTAR
PUSTAKA
..........................................................................................................................

iii

..........................................................................................................................
18

iiii

DAFTAR PUSTAKA
1. Rivers E, Nguyen B, Havstad S, et al. 2001. Early Goal-Directed Therapy
in the Treatment of Severe Sepsis and Septic Shock. New England
Medical Journal 345: 1368-1377.
2. Alberti C, Brun-Buisson C, Burchardi H, et al. 2002. Epidemiology of
sepsis and infection in ICU patients from an international multicenter
cohort study. Intensive Care Med; 28 : 108-21.
3. Levy MM, Fink MP, Marshal JC, et al. 2003. International Sepsis
Definitions Conference. Intensive Care Med; 29 : 530-8.
4. Dellinger RP, Levy MM, Carlet JM, et al. 2008. Surviving Sepsis
Campaign : International guidelines for management of severe sepsis
and septic shock. Critical Care Med; 36 : 296-327.
5. R MacRedmond, K Hollohan, R Stenstrom, et al. 2010. Introduction of
Comprehensive management protocol for severe sepsis is associated
with sustained improvements in timelines of care and survival. Critical
Care Med; 19 : 1.
6. AD Reuben, AV Appelboam, I Higginson, et al. 2006. Early Goal
Directed Therapy : A UK perspective. Emergency Medical Journal; 23.
7. Kern JW, Shoemaker WC. 2002. A meta-analysis of hemodynamic
optimization in high risk patients. Critical Care Medicine; 30 ; 1686-92.
8. Nguyen HB, Corbett SW, Menes K, et al. 2006. Early goal-directed
therapy, corticosteroid and recombinant activated protein C for the
treatment of severe sepsis and septic shock in the emergency
department. Academic Emergency Medicine; 13: 109-113.
9. Jones AE, Kline JA. 2005. Use of goal-directed therapy for severe sepsis
and septic shock in academic emergency departments. Critical Care
Medicine; 33:1888-9.
10. Bateman RM, Walley KR. 2005. Microvascular resuscitation as a
therapeutic goal in severe sepsis. Critical Care; 9:S27-32.

iiv

11. Sakr Y, Dubois MJ, De Backer D, et al. 2004. Persistent

microcirculatory alteration are associated with organ failure and death in
patients with septic shock. Critical Care Medicine; 32:1825-31.
12. Vincent JL, Gerlach H. 2004. Fluid resuscitation in severe sepsis and
septic shock, an evidence based review. Critical Care Medicine; 32: 11.
13. Beale RJ, Hollenberg SM, Vincent JL, et al. 2004. Vasopressor and
inotropic support in septic shock: an evidence-based review. Critical
Care Medicine; 32: S455-65.
14. Reinhart K, Kuhn HJ, Hartog C, et al. 2004. Continous central venous
and pulmonary artery oxygen saturation monitoring in the critical ill.
Intensive Care Medicine; 30: 1572-8.
15. Zimmerman JL. 2004. Use of blood products in sepsis: an evidencebased review. Critical Care Medicine; 32: S542-7.
16. Vincent JL, Piagnerelli M. 2006. Transfusion in the intensive care unit.
Critical Care Medicine; 34: S96-101.
17. Shapiro NI, Howell MD, Talmor D, et al. 2005. Serum lactate as a
predictor of mortality in emergency department patients with infection.
Ann Emergency Medicine; 45: 524-8.
18. Donnino MW, Nguyen B, Jacobsen J, et al. 2003. Cryptic septic shock:
a subanalysis of early goal-directed therapy. Chest; 124:90S.
19. Ronny M, Bryant N, David T, et al. 2006. Early goal-directed therapy in
severe sepsis and septic shock revisited. Chest; 130: 1579-81.
20. Middleton P, Kelly AM, Brown J, et al. 2006. Agreement between
arterial and central venous values for pH, bicarbonate, base excess, and
lactate. Emergency Medicine Journal; 23 : 622-624.
21. Garcia AJ, Sherwin RL, Bilkovski RN. 2006. Point-of-care lactate
testing as a predictor of mortality in a heterogenous emergency
department population. Academic Emergency Medicine; 13:S152.
22. Wira C, Rivers E, Donnino M, et al. 2004. Surrogate markers for lactic
acidosis in patients with severe sepsis and septic shock. Critical Care
Medicine; 32:A151.

iv

23. Nguyen HB, Rivers E, Knoblich BP, et al. 2004. Early lactate clearance
is associated with improved outcome in severe sepsis and septic shock.
Critical Care Medicine; 32:1637-42.
27. Engoren M. 2005. The effect of prompt physician visits on intensive
care unit mortality and cost. Critical Care Medicine; 33:727-32.
28. Levy MM, Dellinger RP, Townsend SR, et al. 2010. The Surviving
sepsis campaign : results of an international guideline-based
performance improvement program targeting severe sepsis. Critical
Care Medicine; 38: 367-74
29. Marik PE, Cavallazi R, Vasu T, et al. 2009. Dynamic changes in arterial
waveform derived variables and fluid responsiveness in mechanically
ventilated patients : a systematic review of the literature. Critical Care
Medicine; 37: 2642-47
30. Ferrer R, Artigas A, Levy MM, et al. 2008. Improvement in process of
care and outcome after a multicenter severe sepsis educational program
in Spain. JAMA 299: 2294-303.
31. Feissel M, Michard F, Faller JP, et al. 2004. The respiratory variation in
inferior vena cava diameter as a guide to fluid therapy. Intensive Care
Medicine; 30: 1834-37
32. Vieillard-Baron A, Prin S, Chergui K, et al. 2003. Hemodynamic
instability in sepsis: bedside assessment by Doppler echocardiography.
Am J Respir Crit Care Med 168: 1270-6.
33. Teboul JL, Monnet X. 2008. Prediction of volume responsiveness in
critically ill patients with spontaneous breathing activity. Current
Opinion Critical Care Medicine; 14: 334-9
34. Benomar B, Ouattara A, Estagnasie P, et al. 2010. Fluid responsiveness
predicted by noninvasive bioreactance-based passive leg raise test.
Intensive Care Medicine; 36: 1875-81
35. De Backer D, Biston P, Devriendt J, et al. 2010. Comparison of
dopamine and norepinephrine in the treatment of shock. NEJM 362: 779
36. Patel GP, Grahe JS, Sperry M, et al. 2010. Efficacy and safety of
dopamine versus norepinephrine in the management of septic shock.
Shock; 33: 375-80.
ivi

37. De Backer D, Aldecoa C, Nijmi H, et al. 2012. Dopamine versus

norepinephrine in the treatment of septic shock : A meta-analysis.
Critical Care Medicine; 40: 725-30.
38. Havel C, Arrich J, Losert H, et al. 2011. Vasopressor for hypotensive
shock. Cochrane database systematic review; 5: CD003709
39. Vasu TS, Cavallazzi R, Hirani A, et al. 2012. Norepinephrine or
dopamine for septic shock: systematic review of randomized clinical
trials. Journal Intensive Care Medicine; 27: 172-8
40. Annane D. 2012. Physicians no longer should consider dopamine for
septic shock. Critical Care Medicine; 40: 981.
41. Spronk PE, Ince C, Gardien MJ, et al. 2002. Nitroglycerin in septic
shock after intravascular volume resuscitation. Lancet; 360: 1395-6.
42. Boerma EC, Koopmans M, Konjin A, et al. 2010. Effects of
nitroglycerin on sublingual microcirculatory blood flow in patients with
severe sepsis / septic shock after a strict resuscitation protocol: A
double-blind randomized placebo controlled trial. Critical Care
Medicine; 38: 93-100.
43. Napolitano LM, Kurek S, Luchete FA, et al. 2009. Clinical practice
guideline : red blood cell transfusion in adult trauma and critical care.
Critical Care Medicine; 37: 3124-57.
44. Dellinger RR. 2003. Cardiovascular management of septic shock.
Critical Care Medicine; 31: 946-55.
45. De Backer D, Creteur J, Dubois MJ, et al. 2006. The effects of
dobutamine on microcirculatory alterations in patients with septic shock
are independent of its systemic effects. Critical Care Medicine; 34: 403
46. Lin SM, Huang CD, Lin HC, et al. 2006. A modified goal-directed
protocol improves clinical outcomes in intensive care unit patients with
septic shock : a randomized controlled trial. Shock; 26 : 551-7
47. Jones AE, Shapiro NI, Trzeciak S, et al. 2010. Lactate clearance versus
central venous oxygen saturation as goals of early sepsis therapy: a
randomized clinical trial. JAMA; 303: 739-46.

ivii